» Articles » PMID: 24399136

Structural Basis for the Recognition of RNA Polymerase II C-terminal Domain by CREPT and P15RS

Overview
Specialties Biology
Science
Date 2014 Jan 9
PMID 24399136
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

CREPT and p15RS are two recently identified homologous proteins that regulate cell proliferation in an opposite way and are closely related to human cancer development. Both CREPT and p15RS consist of an N-terminal RPR domain and a C-terminal domain with high sequence homology. The transcription enhancement by CREPT is attributed to its interaction with RNA polymerase II (Pol II). Here we provide biochemical and structural evidence to support and extend this molecular mechanism. Through fluorescence polarization analysis, we show that the RPR domains of CREPT and p15RS (CREPT-RPR and p15RS-RPR) bind to different Pol II C-terminal domain (CTD) phosphoisoforms with similar affinity and specificity. We also determined the crystal structure of p15RS-RPR. Sequence and structural comparisons with RPR domain of Rtt103, a homolog of CREPT and p15RS in yeast, reveal structural basis for the similar binding profile of CREPT-RPR and p15RS-RPR with Pol II CTD. We also determined the crystal structure of the C-terminal domain of CREPT (CREPT-CTD), which is a long rod-like dimer and each monomer adopts a coiled-coil structure. We propose that dimerization through the C-terminal domain enhances the binding strength between CREPT or p15RS with Pol II by increasing binding avidity. Our results collectively reveal the respective roles of N-terminal RPR domain and C-terminal domain of CREPT and p15RS in recognizing RNA Pol II.

Citing Articles

RPRD1B's direct interaction with phosphorylated RNA polymerase II regulates polyadenylation of cell cycle genes and drives cancer progression.

Moreno R, Panina S, Zhang Y RSC Chem Biol. 2025; 6(3):423-437.

PMID: 39886382 PMC: 11775580. DOI: 10.1039/d4cb00212a.


PROTACs in gastrointestinal cancers.

Chen Y, Yang Q, Xu J, Tang L, Zhang Y, Du F Mol Ther Oncolytics. 2022; 27:204-223.

PMID: 36420306 PMC: 9676279. DOI: 10.1016/j.omto.2022.10.012.


CREPT Disarms the Inhibitory Activity of HDAC1 on Oncogene Expression to Promote Tumorigenesis.

Cao Y, Ning B, Tian Y, Lan T, Chu Y, Ren F Cancers (Basel). 2022; 14(19).

PMID: 36230720 PMC: 9562184. DOI: 10.3390/cancers14194797.


Simplicity is the Ultimate Sophistication-Crosstalk of Post-translational Modifications on the RNA Polymerase II.

Venkat Ramani M, Yang W, Irani S, Zhang Y J Mol Biol. 2021; 433(14):166912.

PMID: 33676925 PMC: 8184622. DOI: 10.1016/j.jmb.2021.166912.


CREPT/RPRD1B promotes tumorigenesis through STAT3-driven gene transcription in a p300-dependent manner.

Zhai W, Ye X, Wang Y, Feng Y, Wang Y, Lin Y Br J Cancer. 2021; 124(8):1437-1448.

PMID: 33531691 PMC: 8039031. DOI: 10.1038/s41416-021-01269-1.